(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 7.64% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 7.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.18%.
Cognex's revenue in 2026 is $1,046,760,000.On average, 25 Wall Street analysts forecast CGNX's revenue for 2026 to be $181,230,782,139, with the lowest CGNX revenue forecast at $168,915,742,765, and the highest CGNX revenue forecast at $193,545,821,513. On average, 24 Wall Street analysts forecast CGNX's revenue for 2027 to be $196,874,210,533, with the lowest CGNX revenue forecast at $176,571,037,511, and the highest CGNX revenue forecast at $217,676,641,908.
In 2028, CGNX is forecast to generate $219,340,836,418 in revenue, with the lowest revenue forecast at $198,538,405,043 and the highest revenue forecast at $243,804,495,715.